Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

RArcus Biosciences, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
R

Arcus Biosciences, Inc.

$26.87Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $41M. Net result −$91M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $41M. Running result $41M. License And Development Services: $16M. Other Collaboration Revenue: $25M.
  • Cost of revenue: $0. Running result $41M.
  • Gross profit: $41M. Running result $41M.
  • Research and development (Includes $2, $11, $2 and $6 from a related party): −$113M. Running result −$72M.
  • General and administrative (Includes $—, $2, $— and $2 from a related party): −$24M. Running result −$96M.
  • Operating income: −$96M. Running result −$96M.
  • Other income: $5M. Running result −$91M.
  • Pre-tax loss: −$91M. Running result −$91M.
  • Income tax benefit: $0. Running result −$91M.
  • Net loss: −$91M. Running result −$91M.